Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data
Recent years have seen an increasing interest in incorporating external control data for designing and evaluating randomized clinical trials (RCT). This may decrease costs and shorten inclusion times by reducing sample sizes. For small populations, with limited recruitment, this can be especially im...
Gespeichert in:
Veröffentlicht in: | Pharmaceutical statistics : the journal of the pharmaceutical industry 2024-09, Vol.23 (5), p.611-629 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 629 |
---|---|
container_issue | 5 |
container_start_page | 611 |
container_title | Pharmaceutical statistics : the journal of the pharmaceutical industry |
container_volume | 23 |
creator | Burman, Carl‐Fredrik Hermansson, Erik Bock, David Franzén, Stefan Svensson, David |
description | Recent years have seen an increasing interest in incorporating external control data for designing and evaluating randomized clinical trials (RCT). This may decrease costs and shorten inclusion times by reducing sample sizes. For small populations, with limited recruitment, this can be especially important. Bayesian dynamic borrowing (BDB) has been a popular choice as it claims to protect against potential prior data conflict. Digital twins (DT) has recently been proposed as another method to utilize historical data. DT, also known as PROCOVA™, is based on constructing a prognostic score from historical control data, typically using machine learning. This score is included in a pre‐specified ANCOVA as the primary analysis of the RCT. The promise of this idea is power increase while guaranteeing strong type 1 error control. In this paper, we apply analytic derivations and simulations to analyze and discuss examples of these two approaches. We conclude that BDB and DT, although similar in scope, have fundamental differences which need be considered in the specific application. The inflation of the type 1 error is a serious issue for BDB, while more evidence is needed of a tangible value of DT for real RCTs. |
doi_str_mv | 10.1002/pst.2376 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2937705305</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2937705305</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3106-6baf13edb76a452b1febf57aaf36a4d02a4618652c51f0f50d7c6acec9c2da213</originalsourceid><addsrcrecordid>eNp1kdtKxDAURYMoXkbBL5CAL75Uc2nTqW_eFQQFx-dwmiYaaZOaZBjm7413EIRAwjmLxSYboV1KDikh7GiM6ZDxWqygTVrxpqCCstWfNyk30FaML4TQetpU62iDT0veUC420XBun2yCHqeFdRGD6_ApLHW04HC3dDBYhVsfgs_rp2M8W3gctNIuYRjH4EE964iND9g65cPoA6QM4mcbkw9WZbHyLgXf4w4SbKM1A33UO1_3BD1eXszOrovbu6ubs5PbQnFKRCFaMJTrrq0FlBVrqdGtqWoAw_OgIwxKQaeiYqqihpiKdLUSoLRqFOuAUT5BB5_eHPF1rmOSg41K9z047edRsobXNal4PhO0_wd98fPgcjrJKWsYYSVpfoUq-BiDNnIMdoCwlJTI9wpkrkC-V5DRvS_hvB109wN-_3kGik9gYXu9_Fck7x9mH8I3KEaRoA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3129202409</pqid></control><display><type>article</type><title>Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Burman, Carl‐Fredrik ; Hermansson, Erik ; Bock, David ; Franzén, Stefan ; Svensson, David</creator><creatorcontrib>Burman, Carl‐Fredrik ; Hermansson, Erik ; Bock, David ; Franzén, Stefan ; Svensson, David</creatorcontrib><description>Recent years have seen an increasing interest in incorporating external control data for designing and evaluating randomized clinical trials (RCT). This may decrease costs and shorten inclusion times by reducing sample sizes. For small populations, with limited recruitment, this can be especially important. Bayesian dynamic borrowing (BDB) has been a popular choice as it claims to protect against potential prior data conflict. Digital twins (DT) has recently been proposed as another method to utilize historical data. DT, also known as PROCOVA™, is based on constructing a prognostic score from historical control data, typically using machine learning. This score is included in a pre‐specified ANCOVA as the primary analysis of the RCT. The promise of this idea is power increase while guaranteeing strong type 1 error control. In this paper, we apply analytic derivations and simulations to analyze and discuss examples of these two approaches. We conclude that BDB and DT, although similar in scope, have fundamental differences which need be considered in the specific application. The inflation of the type 1 error is a serious issue for BDB, while more evidence is needed of a tangible value of DT for real RCTs.</description><identifier>ISSN: 1539-1604</identifier><identifier>ISSN: 1539-1612</identifier><identifier>EISSN: 1539-1612</identifier><identifier>DOI: 10.1002/pst.2376</identifier><identifier>PMID: 38439136</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Inc</publisher><subject>Bayes Theorem ; clinical trials ; Computer Simulation ; Data Interpretation, Statistical ; Digital twins ; Humans ; Machine Learning ; Models, Statistical ; PROCOVA ; prognostic score ; Randomized Controlled Trials as Topic - methods ; Randomized Controlled Trials as Topic - statistics & numerical data ; Research Design ; robust mixture prior ; Sample Size</subject><ispartof>Pharmaceutical statistics : the journal of the pharmaceutical industry, 2024-09, Vol.23 (5), p.611-629</ispartof><rights>2024 John Wiley & Sons Ltd.</rights><rights>2024 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3106-6baf13edb76a452b1febf57aaf36a4d02a4618652c51f0f50d7c6acec9c2da213</cites><orcidid>0000-0001-6104-7150</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpst.2376$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpst.2376$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38439136$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Burman, Carl‐Fredrik</creatorcontrib><creatorcontrib>Hermansson, Erik</creatorcontrib><creatorcontrib>Bock, David</creatorcontrib><creatorcontrib>Franzén, Stefan</creatorcontrib><creatorcontrib>Svensson, David</creatorcontrib><title>Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data</title><title>Pharmaceutical statistics : the journal of the pharmaceutical industry</title><addtitle>Pharm Stat</addtitle><description>Recent years have seen an increasing interest in incorporating external control data for designing and evaluating randomized clinical trials (RCT). This may decrease costs and shorten inclusion times by reducing sample sizes. For small populations, with limited recruitment, this can be especially important. Bayesian dynamic borrowing (BDB) has been a popular choice as it claims to protect against potential prior data conflict. Digital twins (DT) has recently been proposed as another method to utilize historical data. DT, also known as PROCOVA™, is based on constructing a prognostic score from historical control data, typically using machine learning. This score is included in a pre‐specified ANCOVA as the primary analysis of the RCT. The promise of this idea is power increase while guaranteeing strong type 1 error control. In this paper, we apply analytic derivations and simulations to analyze and discuss examples of these two approaches. We conclude that BDB and DT, although similar in scope, have fundamental differences which need be considered in the specific application. The inflation of the type 1 error is a serious issue for BDB, while more evidence is needed of a tangible value of DT for real RCTs.</description><subject>Bayes Theorem</subject><subject>clinical trials</subject><subject>Computer Simulation</subject><subject>Data Interpretation, Statistical</subject><subject>Digital twins</subject><subject>Humans</subject><subject>Machine Learning</subject><subject>Models, Statistical</subject><subject>PROCOVA</subject><subject>prognostic score</subject><subject>Randomized Controlled Trials as Topic - methods</subject><subject>Randomized Controlled Trials as Topic - statistics & numerical data</subject><subject>Research Design</subject><subject>robust mixture prior</subject><subject>Sample Size</subject><issn>1539-1604</issn><issn>1539-1612</issn><issn>1539-1612</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kdtKxDAURYMoXkbBL5CAL75Uc2nTqW_eFQQFx-dwmiYaaZOaZBjm7413EIRAwjmLxSYboV1KDikh7GiM6ZDxWqygTVrxpqCCstWfNyk30FaML4TQetpU62iDT0veUC420XBun2yCHqeFdRGD6_ApLHW04HC3dDBYhVsfgs_rp2M8W3gctNIuYRjH4EE964iND9g65cPoA6QM4mcbkw9WZbHyLgXf4w4SbKM1A33UO1_3BD1eXszOrovbu6ubs5PbQnFKRCFaMJTrrq0FlBVrqdGtqWoAw_OgIwxKQaeiYqqihpiKdLUSoLRqFOuAUT5BB5_eHPF1rmOSg41K9z047edRsobXNal4PhO0_wd98fPgcjrJKWsYYSVpfoUq-BiDNnIMdoCwlJTI9wpkrkC-V5DRvS_hvB109wN-_3kGik9gYXu9_Fck7x9mH8I3KEaRoA</recordid><startdate>202409</startdate><enddate>202409</enddate><creator>Burman, Carl‐Fredrik</creator><creator>Hermansson, Erik</creator><creator>Bock, David</creator><creator>Franzén, Stefan</creator><creator>Svensson, David</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6104-7150</orcidid></search><sort><creationdate>202409</creationdate><title>Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data</title><author>Burman, Carl‐Fredrik ; Hermansson, Erik ; Bock, David ; Franzén, Stefan ; Svensson, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3106-6baf13edb76a452b1febf57aaf36a4d02a4618652c51f0f50d7c6acec9c2da213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Bayes Theorem</topic><topic>clinical trials</topic><topic>Computer Simulation</topic><topic>Data Interpretation, Statistical</topic><topic>Digital twins</topic><topic>Humans</topic><topic>Machine Learning</topic><topic>Models, Statistical</topic><topic>PROCOVA</topic><topic>prognostic score</topic><topic>Randomized Controlled Trials as Topic - methods</topic><topic>Randomized Controlled Trials as Topic - statistics & numerical data</topic><topic>Research Design</topic><topic>robust mixture prior</topic><topic>Sample Size</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burman, Carl‐Fredrik</creatorcontrib><creatorcontrib>Hermansson, Erik</creatorcontrib><creatorcontrib>Bock, David</creatorcontrib><creatorcontrib>Franzén, Stefan</creatorcontrib><creatorcontrib>Svensson, David</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmaceutical statistics : the journal of the pharmaceutical industry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burman, Carl‐Fredrik</au><au>Hermansson, Erik</au><au>Bock, David</au><au>Franzén, Stefan</au><au>Svensson, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data</atitle><jtitle>Pharmaceutical statistics : the journal of the pharmaceutical industry</jtitle><addtitle>Pharm Stat</addtitle><date>2024-09</date><risdate>2024</risdate><volume>23</volume><issue>5</issue><spage>611</spage><epage>629</epage><pages>611-629</pages><issn>1539-1604</issn><issn>1539-1612</issn><eissn>1539-1612</eissn><abstract>Recent years have seen an increasing interest in incorporating external control data for designing and evaluating randomized clinical trials (RCT). This may decrease costs and shorten inclusion times by reducing sample sizes. For small populations, with limited recruitment, this can be especially important. Bayesian dynamic borrowing (BDB) has been a popular choice as it claims to protect against potential prior data conflict. Digital twins (DT) has recently been proposed as another method to utilize historical data. DT, also known as PROCOVA™, is based on constructing a prognostic score from historical control data, typically using machine learning. This score is included in a pre‐specified ANCOVA as the primary analysis of the RCT. The promise of this idea is power increase while guaranteeing strong type 1 error control. In this paper, we apply analytic derivations and simulations to analyze and discuss examples of these two approaches. We conclude that BDB and DT, although similar in scope, have fundamental differences which need be considered in the specific application. The inflation of the type 1 error is a serious issue for BDB, while more evidence is needed of a tangible value of DT for real RCTs.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Inc</pub><pmid>38439136</pmid><doi>10.1002/pst.2376</doi><tpages>19</tpages><orcidid>https://orcid.org/0000-0001-6104-7150</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1539-1604 |
ispartof | Pharmaceutical statistics : the journal of the pharmaceutical industry, 2024-09, Vol.23 (5), p.611-629 |
issn | 1539-1604 1539-1612 1539-1612 |
language | eng |
recordid | cdi_proquest_miscellaneous_2937705305 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Bayes Theorem clinical trials Computer Simulation Data Interpretation, Statistical Digital twins Humans Machine Learning Models, Statistical PROCOVA prognostic score Randomized Controlled Trials as Topic - methods Randomized Controlled Trials as Topic - statistics & numerical data Research Design robust mixture prior Sample Size |
title | Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T12%3A25%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Digital%20twins%20and%20Bayesian%20dynamic%20borrowing:%20Two%20recent%20approaches%20for%20incorporating%20historical%20control%20data&rft.jtitle=Pharmaceutical%20statistics%20:%20the%20journal%20of%20the%20pharmaceutical%20industry&rft.au=Burman,%20Carl%E2%80%90Fredrik&rft.date=2024-09&rft.volume=23&rft.issue=5&rft.spage=611&rft.epage=629&rft.pages=611-629&rft.issn=1539-1604&rft.eissn=1539-1612&rft_id=info:doi/10.1002/pst.2376&rft_dat=%3Cproquest_cross%3E2937705305%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3129202409&rft_id=info:pmid/38439136&rfr_iscdi=true |